GlassScriptPhysician profile
Jason T Smith
NPI 1053419341
$8,157.20
in general payments reported to CMS, 2019-2025
36 companies · $3,186 in 2025
The $3,186 reported for 2025 was more than what 84% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2020: $217 · 2021: $109 · 2022: $942 · 2023: $1,539 · 2024: $1,817 · 2025: $3,186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,422 · Travel and Lodging: $1,104 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,422.22 |
| Travel and Lodging | $1,103.95 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,629.05 | 2019-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Histosonics, INC. | $1,103.95 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $887.79 | 2019-2025 | Airsupra, Breztri, Tezspire |
| Insmed, INC. | $496.07 | 2019-2025 | Arikayce, Brinsupri |
| Genzyme Corporation | $389.23 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $380.79 | 2020-2025 | Glassia, Cuvitru |
| Regeneron Healthcare Solutions, INC. | $333.04 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $332.32 | 2019-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $315.59 | 2019-2024 | Yupelri |
| Jazz Pharmaceuticals INC. | $254.75 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $237.67 | 2022-2024 | |
| Harmony Biosciences LLC | $207.08 | 2022-2025 | Wakix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $176.34 | 2019-2025 | Ofev |
| Pulmonx Corporation | $163.40 | 2023-2025 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Actelion Pharmaceuticals US, INC. | $159.28 | 2019-2024 | Uptravi, Opsumit |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $113.75 | 2022 | |
| Amgen INC. | $108.03 | 2022-2025 | Tezspire |
| Avadel Cns Pharmaceuticals, LLC | $99.30 | 2024-2025 | Lumryz |
| Philips North America LLC | $78.90 | 2022-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Axsome Therapeutics, INC. | $77.80 | 2023-2025 | Sunosi |
| Baxter Healthcare | $70.46 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Merit Medical Systems INC | $69.58 | 2025 | Esophyx |
| Merck Sharp & Dohme LLC | $60.95 | 2019-2025 | Keytruda |
| Genentech USA, INC. | $54.90 | 2019-2024 | Xolair |
| Viatris Specialty LLC | $51.69 | 2025 | Yupelri |
| Vifor Pharma, INC. | $48.32 | 2024-2025 | Zemaira |
| Astellas Pharma US INC | $38.81 | 2024 | Veozah |
| Pfizer INC. | $35.19 | 2023-2024 | |
| Csl Behring | $34.80 | 2024 | Kcentra |
| Ceribell, INC. | $31.12 | 2023-2025 | Pocket Eeg Device, Ceribell Rapid Response Eeg |
| Ambu INC. | $30.40 | 2024 | |
| Verona Pharma, INC. | $25.25 | 2025 | Ohtuvayre |
| Gilead Sciences, INC. | $17.93 | 2022 | |
| Pharming Healthcare, INC. | $16.11 | 2023 | Ruconest |
| Electromed, INC. | $14.07 | 2019 | |
| Lilly USA, LLC | $13.49 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.